查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1709478

慢性静脉闭塞治疗市场，按产品类型、按治疗类型、按诊断、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Chronic Venous Occlusions Treatment Market, By Product Type, By Treatment Type, By Diagnosis, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年慢性静脉闭塞治疗市场规模价值 72.0943 亿美元，2025 年至 2032 年的复合年增长率为 5.80%。

慢性静脉闭塞治疗市场-市场动态

静脉疾病盛行率上升和技术进步推动慢性静脉闭塞治疗市场成长

慢性静脉功能不全和深部静脉栓塞等静脉疾病的盛行率不断上升，加上微创治疗技术的进步，极大地推动了慢性静脉闭塞 (CVO) 治疗市场的成长。根据世界卫生组织 (WHO) 的数据，静脉疾病影响全球约 30% 的成年人口，而人口老化和久坐的生活方式则加剧了这一负担。例如，美国国立卫生研究院 (NIH) 报告称，仅在美国，每年就有超过 60 万例新的静脉血栓栓塞症病例被诊断出来。生物可吸收支架和改进的溶栓技术等创新正在提高治疗效果，而政府改善新兴经济体医疗基础设施的措施正在为市场扩张创造新的机会。然而，治疗费用高昂以及在农村地区获得高级护理的机会有限等挑战仍然是广泛采用的关键障碍。

慢性静脉闭塞治疗市场—关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 5.80%。

根据产品类型细分，预计静脉支架和抗凝血剂将在 2024 年占据最大市场份额

根据治疗类型细分，静脉注射消融和血栓溶解治疗是 2024 年的主要治疗类型

根据诊断细分，双功能超音波是 2024 年领先的诊断

按地区划分，北美是 2024 年的主要收入来源

慢性静脉闭塞治疗市场-細項分析：

全球慢性静脉闭塞治疗市场根据产品类型、治疗类型、诊断、最终用户和地区进行细分。

根据产品类型，市场分为四类：压力袜、静脉支架、抗凝血剂、硬化疗法药物和其他。静脉支架和抗凝血剂因其在治疗严重闭塞方面的功效而占据主导地位，而压力袜在早期管理和预防护理中仍然很受欢迎。

根据治疗类型，市场分为两类：压迫疗法、药物治疗、静脉注射消融、手术介入和血栓溶解疗法。静脉注射消融和血栓溶解治疗因其微创性和有效性而被广泛应用，而压迫疗法仍广泛用于早期治疗。

慢性静脉闭塞治疗市场-地理洞察

慢性静脉闭塞 (CVO) 治疗市场表现出明显的地区差异，这是由医疗保健基础设施、疾病流行程度和获得先进治疗的机会的差异所致。北美占据市场主导地位，得益于其静脉疾病的高发性、强大的医疗保健系统以及创新技术的早期采用，而由于深部静脉血栓形成和慢性静脉功能不全病例的增加，美国占据了相当大的份额。欧洲紧随其后，受人口老化和政府资助的医疗保健计划的推动，尤其是德国和英国等国家。预计亚太地区将因医疗保健支出增加、医疗设施改善以及人们对静脉疾病的认识不断提高而快速增长，其中中国和印度等国家将处于领先地位。同时，拉丁美洲和中东及非洲面临医疗保健服务有限等挑战，但他们透过投资医疗基础设施和越来越多地采用微创治疗，逐步扩大其市场份额。

慢性静脉闭塞治疗市场-竞争格局：

慢性静脉闭塞 (CVO) 治疗市场竞争激烈，既有成熟的医疗器材公司，也有新兴的参与者，并且有旨在创新和扩大市场的策略合作。美敦力、波士顿科学和飞利浦医疗等主要参与者占据市场主导地位，利用其广泛的产品组合和强大的分销网络保持竞争优势。这些公司正积极投资研发，推出生物可吸收支架和下一代血栓溶解装置等先进解决方案。规模较小的公司和新创公司也透过专注于细分市场和具有成本效益的治疗方法而获得了关注。策略合作伙伴关係、合併和收购很常见，因为公司的目标是增强其技术能力和地理影响力。此外，监管部门的批准和临床试验在塑造竞争动态方面发挥着至关重要的作用，参与者努力满足严格的安全性和有效性标准。全球对微创治疗的需求不断增加以及静脉疾病的日益普及进一步加剧了市场的竞争强度。

最新动态：

2024 年 6 月，飞利浦推出了双静脉支架系统，这是一种用于治疗慢性静脉功能不全 (CVI) 患者症状性静脉流出道阻塞的设备。该系统由两个支架组成，专为应对静脉解剖的独特挑战而设计，并在 VIVID 研究中证明了其安全性和有效性。

2024 年 7 月，Inari 扩大了其设备组合，推出了经 FDA 批准的 VenaCore，这是一种用于週边血管的微创血栓切除导管。 VenaCore 具有带槽口的取芯元件和可折迭手柄，可有效减容并去除顽固的静脉阻塞物，增强对复杂血管阻塞的治疗。

目录

第一章：慢性静脉闭塞治疗市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 慢性静脉闭塞症治疗市场（依产品类型）
    • 慢性静脉闭塞症治疗市场片段（依治疗类型）
    • 慢性静脉闭塞症治疗市场（依诊断）
    • 慢性静脉闭塞治疗市场（依最终使用者）
    • 慢性静脉闭塞症治疗市场（依国家/地区）
    • 慢性静脉闭塞症治疗市场（按地区）
  • 竞争洞察

第三章：慢性静脉闭塞症治疗的主要市场趋势

  • 慢性静脉闭塞治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 慢性静脉闭塞症治疗市场限制
    • 市场限制的影响分析
  • 慢性静脉闭塞治疗市场机会
  • 慢性静脉闭塞症治疗市场未来趋势

第四章：慢性静脉闭塞症治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：慢性静脉闭塞治疗市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：慢性静脉闭塞症治疗市场格局

  • 慢性静脉闭塞症治疗市占率分析（2024年）
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：慢性静脉闭塞症治疗市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 压力袜
    • 静脉支架
    • 抗凝血剂
    • 硬化疗法药物
    • 其他的

第 8 章：慢性静脉闭塞症治疗市场 - 依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 压迫疗法
    • 药物治疗
    • 静脉内消融术
    • 外科手术干预
    • 溶栓治疗

第九章：慢性静脉闭塞症治疗市场－依诊断

  • 概述
    • 按诊断进行细分份额分析
    • 双功能超音波
    • 静脉造影
    • 磁振造影静脉摄影
    • 其他的

第 10 章：慢性静脉闭塞治疗市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 门诊手术中心
    • 专科诊所
    • 居家照护环境

第 11 章：慢性静脉闭塞症治疗市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美慢性静脉闭塞治疗主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测，按治疗类型
    • 北美市场规模及预测（按诊断）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲慢性静脉闭塞治疗主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模及预测（按治疗类型）
    • 欧洲市场规模及预测（依诊断）
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区慢性静脉闭塞治疗主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依治疗类型）
    • 亚太地区市场规模及预测（依诊断）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲慢性静脉闭塞治疗主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按治疗类型）
    • 拉丁美洲市场规模及预测（依诊断）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲慢性静脉闭塞治疗主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（依治疗类型）
    • MEA 市场规模及预测（依诊断）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：关键供应商分析-慢性静脉闭塞治疗产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • AngioDynamics, Inc.
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • BTG International Ltd.
    • Cardinal Health, Inc.
    • Cook Medical
    • Endologix, Inc.
    • Koninklijke Philips NV
    • LeMaitre Vascular, Inc.
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Corporation
    • Vascular Solutions, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4913

REPORT HIGHLIGHT

Chronic Venous Occlusions Treatment Market size was valued at US$ 7,209.43 Million in 2024, expanding at a CAGR of 5.80% from 2025 to 2032.

The Chronic Venous Occlusions (CVO) Treatment Market focuses on addressing blockages in the venous system, often caused by deep vein thrombosis or chronic venous insufficiency, through interventions like angioplasty, stenting, and thrombolysis. Increasing prevalence of venous diseases, advancements in minimally invasive surgical techniques, and rising awareness about early diagnosis are propelling market growth, with over 30% of adults estimated to suffer from some form of venous disorder globally. However, high treatment costs and limited access to advanced healthcare in developing regions act as significant restraints. Opportunities lie in the development of innovative bioabsorbable stents and the expansion of telemedicine for post-treatment care, particularly in underserved areas. Additionally, the growing aging population, which is more susceptible to venous disorders, further underscores the potential for market expansion.

Chronic Venous Occlusions Treatment Market- Market Dynamics

Rising Prevalence of Venous Disorders and Technological Advancements to Drive Chronic Venous Occlusions Treatment Market Growth

The rising prevalence of venous disorders, such as chronic venous insufficiency and deep vein thrombosis, coupled with advancements in minimally invasive treatment technologies, is significantly driving the growth of the Chronic Venous Occlusions (CVO) Treatment Market. According to the World Health Organization (WHO), venous diseases affect approximately 30% of the global adult population, with aging populations and sedentary lifestyles contributing to the increasing burden. For instance, the National Institutes of Health (NIH) reports that over 600,000 new cases of venous thromboembolism are diagnosed annually in the United States alone. Innovations like bioabsorbable stents and improved thrombolysis techniques are enhancing treatment outcomes, while government initiatives to improve healthcare infrastructure in emerging economies are creating new opportunities for market expansion. However, challenges such as high treatment costs and limited access to advanced care in rural areas remain critical barriers to widespread adoption.

Chronic Venous Occlusions Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2025-2032)

Based on product type segmentation, Venous stents and anticoagulants was predicted to show maximum market share in the year 2024

Based on Treatment Type segmentation, Endovenous ablation and thrombolytic therapy was the leading Treatment Type in 2024

Based on Diagnosis segmentation, Duplex Ultrasound was the leading Diagnosis in 2024

On the basis of region, North America was the leading revenue generator in 2024

Chronic Venous Occlusions Treatment Market- Segmentation Analysis:

The Global Chronic Venous Occlusions Treatment Market is segmented on the basis of Product Type, Treatment Type, Diagnosis, End-User, and Region.

The market is divided into four categories based on product type: Compression stockings, venous stents, anticoagulants, sclerotherapy agents, and others. Venous stents and anticoagulants dominate due to their efficacy in treating severe occlusions, while compression stockings remain popular for early-stage management and preventive care.

The market is divided into two categories based on Treatment Type: Compression therapy, pharmacological treatment, endovenous ablation, surgical interventions, and thrombolytic therapy. Endovenous ablation and thrombolytic therapy are widely used due to their minimally invasive nature and effectiveness, while compression therapy remains widely used for early-stage management.

Chronic Venous Occlusions Treatment Market- Geographical Insights

The Chronic Venous Occlusions (CVO) Treatment Market exhibits significant regional variation, driven by differences in healthcare infrastructure, disease prevalence, and access to advanced treatments. North America dominates the market, supported by a high prevalence of venous disorders, robust healthcare systems, and early adoption of innovative technologies, with the U.S. accounting for a substantial share due to rising cases of deep vein thrombosis and chronic venous insufficiency. Europe follows closely, driven by aging populations and government-funded healthcare initiatives, particularly in countries like Germany and the UK. The Asia-Pacific region is expected to witness rapid growth due to increasing healthcare expenditure, improving access to medical facilities, and a growing awareness of venous diseases, with countries like China and India leading the way. Meanwhile, Latin America and the Middle East & Africa face challenges such as limited healthcare access but are gradually expanding their market presence through investments in healthcare infrastructure and rising adoption of minimally invasive treatments.

Chronic Venous Occlusions Treatment Market- Competitive Landscape:

The Chronic Venous Occlusions (CVO) Treatment Market features a competitive landscape characterized by the presence of established medical device companies, emerging players, and strategic collaborations aimed at innovation and market expansion. Key players such as Medtronic, Boston Scientific, and Philips Healthcare dominate the market, leveraging their extensive product portfolios and strong distribution networks to maintain a competitive edge. These companies are actively investing in research and development to introduce advanced solutions like bioabsorbable stents and next-generation thrombolysis devices. Smaller firms and startups are also gaining traction by focusing on niche segments and cost-effective treatments. Strategic partnerships, mergers, and acquisitions are common, as companies aim to enhance their technological capabilities and geographic reach. Additionally, regulatory approvals and clinical trials play a crucial role in shaping the competitive dynamics, with players striving to meet stringent safety and efficacy standards. The market's competitive intensity is further fueled by increasing demand for minimally invasive treatments and the growing prevalence of venous disorders worldwide.

Recent Developments:

In June 2024, Philips has launched the Duo Venous Stent System, a device to treat symptomatic venous outflow obstruction in chronic venous insufficiency (CVI) patients. The system, comprised of two stents, is designed for the unique challenges of venous anatomy and demonstrated safety and efficacy in the VIVID study.

In July 2024, Inari expanded its device portfolio with FDA-cleared VenaCore, a minimally invasive thrombectomy catheter for peripheral vasculature. Featuring a notched coring element and collapsible handle, VenaCore efficiently debulks and removes tough venous occlusions, enhancing treatment for complex vascular blockages.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cardinal Health, Inc.
  • Cook Medical
  • Endologix, Inc.
  • Koninklijke Philips N.V.
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions, Inc.
  • Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Compression Stockings
  • Venous Stents
  • Anticoagulants
  • Sclerotherapy Agents
  • Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Compression Therapy
  • Pharmacological Treatment
  • Endovenous Ablation
  • Surgical Interventions
  • Thrombolytic Therapy

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Duplex Ultrasound
  • Venography
  • Magnetic Resonance Venography
  • Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Care Settings

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chronic Venous Occlusions Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronic Venous Occlusions Treatment Market Snippet by Product Type
    • 2.1.2. Chronic Venous Occlusions Treatment Market Snippet by Treatment Type
    • 2.1.3. Chronic Venous Occlusions Treatment Market Snippet by Diagnosis
    • 2.1.4. Chronic Venous Occlusions Treatment Market Snippet by End-User
    • 2.1.5. Chronic Venous Occlusions Treatment Market Snippet by Country
    • 2.1.6. Chronic Venous Occlusions Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronic Venous Occlusions Treatment Key Market Trends

  • 3.1. Chronic Venous Occlusions Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronic Venous Occlusions Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronic Venous Occlusions Treatment Market Opportunities
  • 3.4. Chronic Venous Occlusions Treatment Market Future Trends

4. Chronic Venous Occlusions Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronic Venous Occlusions Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Chronic Venous Occlusions Treatment Market Landscape

  • 6.1. Chronic Venous Occlusions Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronic Venous Occlusions Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Compression Stockings
    • 7.1.3. Venous Stents
    • 7.1.4. Anticoagulants
    • 7.1.5. Sclerotherapy Agents
    • 7.1.6. Others

8. Chronic Venous Occlusions Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 8.1.2. Compression Therapy
    • 8.1.3. Pharmacological Treatment
    • 8.1.4. Endovenous Ablation
    • 8.1.5. Surgical Interventions
    • 8.1.6. Thrombolytic Therapy

9. Chronic Venous Occlusions Treatment Market - By Diagnosis

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Diagnosis, 2024 & 2032 (%)
    • 9.1.2. Duplex Ultrasound
    • 9.1.3. Venography
    • 9.1.4. Magnetic Resonance Venography
    • 9.1.5. Others

10. Chronic Venous Occlusions Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Specialty Clinics
    • 10.1.5. Home Care Settings

11. Chronic Venous Occlusions Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Chronic Venous Occlusions Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Chronic Venous Occlusions Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Chronic Venous Occlusions Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Chronic Venous Occlusions Treatment Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Chronic Venous Occlusions Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Venous Occlusions Treatment Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. AngioDynamics, Inc.
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Boston Scientific Corporation
    • 12.2.5. BTG International Ltd.
    • 12.2.6. Cardinal Health, Inc.
    • 12.2.7. Cook Medical
    • 12.2.8. Endologix, Inc.
    • 12.2.9. Koninklijke Philips N.V.
    • 12.2.10. LeMaitre Vascular, Inc.
    • 12.2.11. Medtronic plc
    • 12.2.12. Merit Medical Systems, Inc.
    • 12.2.13. Stryker Corporation
    • 12.2.14. Teleflex Incorporated
    • 12.2.15. Terumo Corporation
    • 12.2.16. Vascular Solutions, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us